The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 27, 2018

Filed:

Apr. 01, 2015
Applicants:

Inserm (Institut National DE LA Santé ET DE LA Recherche Médicale), Paris, FR;

Université DE Nantes, Nantes, FR;

Inventors:

Carole Guillonneau, Nantes, FR;

Ignacio Anegon, Nantes, FR;

Elodie Picarda, Nantes, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 38/00 (2006.01); A61K 35/12 (2015.01); C07K 7/08 (2006.01); C07K 14/74 (2006.01); C12N 5/0783 (2010.01); G01N 33/50 (2006.01); A61K 35/17 (2015.01); C07K 7/06 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
A61K 39/001 (2013.01); A61K 35/17 (2013.01); C07K 7/06 (2013.01); C07K 7/08 (2013.01); C07K 14/70539 (2013.01); C12N 5/0637 (2013.01); G01N 33/505 (2013.01); G01N 33/56972 (2013.01); A61K 38/00 (2013.01); A61K 2035/122 (2013.01); A61K 2039/577 (2013.01); C12N 2501/998 (2013.01); C12N 2502/1121 (2013.01); G01N 2333/70517 (2013.01); G01N 2333/70589 (2013.01); G01N 2800/245 (2013.01); G01N 2800/52 (2013.01);
Abstract

The invention relates to an peptide derived from a polymorphic region of donor MHC class II molecules which induces tolerance and thus prevents transplant rejection in a patient in need thereof. The invention relates to isolated peptide of length ranging between 11 and 16 amino acids comprising the amino acid sequence: SDVGEYR (SEQ ID NO: 1) or a function-conservative variant thereof for use as drug. The invention relates to an in vitro method for determining whether a transplanted patient is tolerant, comprising a step of determining the presence of CD8+CD45RCTregs in a biological sample obtained from said transplanted patient, wherein the presence of CD8CD45RCTregs is indicative of tolerance.


Find Patent Forward Citations

Loading…